These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22113368)

  • 1. Evaluation of a telemedicine service for the secondary prevention of coronary artery disease.
    Blasco A; Carmona M; Fernández-Lozano I; Salvador CH; Pascual M; Sagredo PG; Somolinos R; Muñoz A; García-López F; Escudier JM; Mingo S; Toquero J; Moñivas V; González MA; Fragua JA; López-Rodríguez F; Monteagudo JL; Alonso-Pulpón L
    J Cardiopulm Rehabil Prev; 2012; 32(1):25-31. PubMed ID: 22113368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
    Maron DJ; Boden WE; O'Rourke RA; Hartigan PM; Calfas KJ; Mancini GB; Spertus JA; Dada M; Kostuk WJ; Knudtson M; Harris CL; Sedlis SP; Zoble RG; Title LM; Gosselin G; Nawaz S; Gau GT; Blaustein AS; Bates ER; Shaw LJ; Berman DS; Chaitman BR; Weintraub WS; Teo KK;
    J Am Coll Cardiol; 2010 Mar; 55(13):1348-58. PubMed ID: 20338496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-centered modular secondary prevention following acute coronary syndrome: a randomized controlled trial.
    Redfern J; Briffa T; Ellis E; Freedman SB
    J Cardiopulm Rehabil Prev; 2008; 28(2):107-15; quiz 116-7. PubMed ID: 18360186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.
    Jacobson TA; Gutkin SW; Harper CR
    Curr Med Res Opin; 2006 Jun; 22(6):1065-73. PubMed ID: 16846539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of patient-general practitioner short-messages-based interaction on the control of hypertension in a follow-up service for low-to-medium risk hypertensive patients: a randomized controlled trial.
    Carrasco MP; Salvador CH; Sagredo PG; Márquez-Montes J; González de Mingo MA; Fragua JA; Rodríguez MC; García-Olmos LM; García-López F; Carrero AM; Monteagudo JL
    IEEE Trans Inf Technol Biomed; 2008 Nov; 12(6):780-91. PubMed ID: 19000959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention after acute coronary syndrome: therapeutic goals achievement in relation with changes in guidelines].
    Galuscan G; Georges JL; Gardenat-Leboidre S; Gibault-Genty G; Stefas L; Maspoli JJ; Blanquart JP; Aziza JP; Schwob J; Normand JP; Livarek B
    Ann Cardiol Angeiol (Paris); 2008 Nov; 57(5):268-74. PubMed ID: 18937926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Profile of risk factors modification after coronary revascularization in patients with coronary artery disease].
    Nie SP; Liu XH; Du X; Kang JP; Lü Q; Dong JZ; Gu CX; Huang FJ; Zhou YJ; Li ZZ; Chen F; Lü SZ; Wu XS; Ma CS
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1097-101. PubMed ID: 16796833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiology management improves secondary prevention measures among patients with coronary artery disease.
    Ho PM; Masoudi FA; Peterson ED; Grunwald GK; Sales AE; Hammermeister KE; Rumsfeld JS
    J Am Coll Cardiol; 2004 May; 43(9):1517-23. PubMed ID: 15120805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Artery RIsk MAnagement Programme (CARIMAP) delivered by a rehabilitation day-hospital: impact on patients with coronary artery disease.
    Sturchio A; Di Gianni A; Campana B; Genua M; Storti M; Di Iasi G; Monaco S; Colella M; dello Buono A; D'Addese E; Capomolla S
    J Cardiopulm Rehabil Prev; 2012; 32(6):386-93. PubMed ID: 23103475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease: a PreCIS database study.
    Gambino KK; Zumpano J; Brennan DM; Hoogwerf BJ
    J Cardiovasc Nurs; 2010; 25(2):99-105. PubMed ID: 20168189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe.
    Vranckx P; Boersma E; Garg S; Valgimigli M; Van Es GA; Goedhart D; Serruys PW
    EuroIntervention; 2011 Nov; 7(7):859-71. PubMed ID: 22082582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized community cholesterol control (4C): meeting the challenge of secondary prevention.
    Gilutz H; Novack L; Shvartzman P; Zelingher J; Bonneh DY; Henkin Y; Maislos M; Peleg R; Liss Z; Rabinowitz G; Vardy D; Zahger D; Ilia R; Leibermann N; Porath A
    Isr Med Assoc J; 2009 Jan; 11(1):23-9. PubMed ID: 19344008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year follow-up of the Choice of Health Options In prevention of Cardiovascular Events randomized controlled trial.
    Neubeck L; Freedman SB; Briffa T; Bauman A; Redfern J
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):278-86. PubMed ID: 20606594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.